Epoprostenol for severe frostbite
Part of Injuries & trauma clinical trials.
This trial tests whether adding epoprostenol to standard care can help people with severe frostbite avoid amputation. Epoprostenol is a medicine that opens blood vessels to improve blood flow to damaged tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are admitted to the University of Colorado Hospital Burn and Frostbite Center
- Your frostbite is grade 2, 3, or 4 (moderate to very severe)
- You can start the study treatment within 3 days (72 hours) after rewarming
- You are not pregnant or breastfeeding
- You do not have certain heart or blood pressure problems, such as heart failure or very low blood pressure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well different treatments (like aloe vera, silver, and an antibiotic called dalbavancin) prevent and treat infections in people with frostbite. It also studies how these medicines work in the body.
This study tests a medication called Iloprost, given through an IV, to treat severe frostbite at high altitudes. It may help save damaged tissue and prevent amputation.
This trial tests a medication called treprostinil to see if it can help people who have frequent Raynaud's attacks. It is for patients with primary or secondary Raynaud's (related to conditions like scleroderma or lupus) who still have attacks despite current treatments.
This study tests a medicine called prostacyclin (given through a vein) to see if it helps people on a breathing machine with a lung infection. The goal is to reduce inflammation and improve recovery.
This early-phase study tests whether treprostinil (Remodulin®) can reduce injury to a transplanted kidney right after surgery. If it works and is safe, it may help improve outcomes for people receiving a deceased-donor kidney transplant.
This trial tests if inhaling a drug called iloprost can help patients who have both severe COPD and high blood pressure in the lungs (pulmonary hypertension). It may improve blood flow and symptoms.
Hear when a new Frostbite trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.